Michael A. Vavuranakis (@vavuranakis) 's Twitter Profile
Michael A. Vavuranakis

@vavuranakis

Cardiology Fellow @SinaiCards via @EmoryDeptofMed IM | T32 postdoc fellow @hopkinsheart | PhD @uoaofficial| MD @upatras | 🇬🇷 🇺🇸

ID: 1168538632262750210

linkhttps://www.linkedin.com/in/michael-a-vavuranakis-6662768a/ calendar_today02-09-2019 14:58:21

96 Tweet

235 Followers

515 Following

Thorsten Leucker (@tleucker) 's Twitter Profile Photo

👉Our 🌟postdoc Efthymios (Timos) Ziogos is climbing the stage at #ESCCongress in Barcelona tomorrow to present: “The impact of PCSK9 inhibition with evolocumab on platelet function in acute MI”.📻in at 9:40am(ET). Johns Hopkins Cardiology Michael A. Vavuranakis Michael J. Blaha Steven Schulman Roger Blumenthal

Johns Hopkins Cardiology (@hopkinsheart) 's Twitter Profile Photo

🎊🎉🎊Big congratulations 🎊🎉🎊 to our official new program director, Thorsten Leucker. He has been a huge part of fellow development in our program for many years and we could not be more thrilled to have him as PD! Scroll below to learn a little more about him 👇👇

🎊🎉🎊Big congratulations 🎊🎉🎊 to our official new program director, <a href="/TLeucker/">Thorsten Leucker</a>. He has been a huge part of fellow development in our program for many years and we could not be more thrilled to have him as PD! 

Scroll below to learn a little more about him 👇👇
Leslie Sam Kim (@lesliesamkim) 's Twitter Profile Photo

Marrying a stutterer changed my life. Our first date was difficult. I'd forgotten he'd written the word "stutterer" somewhere in his Bumble profile. We met at the base of a local hike — just as storm clouds were rolling in. It took at least a minute for him to say "Hello."

Nick Mark MD (@nickmmark) 's Twitter Profile Photo

Much has been made of the declining life expectancy in the US. The reality is regional. Think of the US as two countries: Some blue counties with increasing life-expectancy better than 🇯🇵 (84) & many red counties with plummeting life expectancy worse than 🇷🇺 (71). 1/

Much has been made of the declining life expectancy in the US. 

The reality is regional. Think of the US as two countries:

Some blue counties with increasing life-expectancy better than 🇯🇵 (84) &amp; many red counties with plummeting life expectancy worse than 🇷🇺 (71).
1/
Youssef Saklawi (@saklawimd) 's Twitter Profile Photo

So you’re telling me that my clinic patient without ascites or jaundice has cirrhosis? In our @cpsolvers management reasoning virtual morning report, we talked about cirrhosis, a 🧵

Stefan Milutinovic (@stefankmil) 's Twitter Profile Photo

📄 20 studies that Internal Medicine Residents should read in the first year 👇 1/ 🏃‍♀️ RACE II trial: Lenient resting HR < 110 was non-inferior to a strict HR < 80 in patients with atrial fibrillation. 🧵

📄 20 studies that Internal Medicine Residents should read in the first year 👇

1/ 🏃‍♀️ RACE II trial: Lenient resting HR &lt; 110 was non-inferior to a strict HR &lt; 80 in patients with atrial fibrillation. 

🧵
Thorsten Leucker (@tleucker) 's Twitter Profile Photo

👉Congratulations to our 🌠 postdoc Efthymios (Timos) Ziogos for this important piece! Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition academic.oup.com/ehjcvp/article… Johns Hopkins Cardiology The Osler Medical Residency Michael A. Vavuranakis

Efthymios (Timos) Ziogos (@tziogos) 's Twitter Profile Photo

Glad to see our manuscript on the impact of PCSK9 inhibition on platelet activation and endothelial dysfunction published. Couldn't have done this without the unparallel mentorship of Drs. Thorsten Leucker and Gerstenblith. Tarek Harb Michael A. Vavuranakis academic.oup.com/ehjcvp/advance…

Abdulla A. Damluji, MD, PhD (@drdamluji) 's Twitter Profile Photo

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: JACC Journals * I am reading this slowly: let's summarize in threads Read full document:🥸 Thread #1 👇👇👇

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: <a href="/JACCJournals/">JACC Journals</a> 

* I am reading this slowly: let's summarize in threads 

Read full document:🥸 

Thread #1 👇👇👇
Frans Beerkens (@fbeerkens) 's Twitter Profile Photo

Excited to share our JACC Journals State-of-the-Art Review exploring the expanding role of #TAVR beyond severe #AS. From younger patients and bicuspid valves to asymptomatic and moderate AS, we dive into the latest evidence & future challenges. 🔗bit.ly/4h1keUA

Excited to share our <a href="/JACCJournals/">JACC Journals</a> State-of-the-Art Review exploring the expanding role of #TAVR beyond severe #AS. 

From younger patients and bicuspid valves to asymptomatic and moderate AS, we dive into the latest evidence &amp; future challenges.

🔗bit.ly/4h1keUA
Michael A. Vavuranakis (@vavuranakis) 's Twitter Profile Photo

Honored to see the first study I contributed to as a postdoc published. Grateful to the mentors, collaborators, and patients who made this milestone possible. Don’t miss Efthymios (Timos) Ziogos’s must-read thread on PCSK9 inhibition & post-MI inflammation.